Dilaudid Injection, Solution
Product Images NDC 76045-009

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Dilaudid (NDC 76045-009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dilau-struc-01.jpg (Dilau Struc 01)

Chemical structure of hydromorphone hydrochloride, the active ingredient in Dilaudid. The diagram shows the molecular framework with rings, hydroxyl group, methylated nitrogen, and hydrochloride component.*

FDA Label Image

Dilau-img-02.jpg (Dilau Img 02)

An instructional illustration showing a person holding and twisting the cap on a medication vial or syringe, demonstrating the proper way to open or secure the cap. The image is black and white and focuses on hand positioning for handling the closure.*

FDA Label Image

Dilau-img-03.jpg (Dilau Img 03)

An instructional illustration showing two hands connecting a syringe to a vial or ampule. The image guides the user on how to attach the syringe properly for medication preparation or administration.*

FDA Label Image

Dilau-img-04.jpg (Dilau Img 04)

An instructional illustration showing two hands holding a small cylindrical object, with an arrow indicating a twisting or turning action. Likely depicts how to operate or open a component related to Dilaudid, a medication by Fresenius Kabi USA, LLC.*

FDA Label Image

Dilau-img-05.jpg (Dilau Img 05)

FDA Label Image

Dilau-img-01.jpg (Dilau Img 01)

An instructional diagram showing the parts of a syringe, including the outer package, cap, tamper evident seal, tube, plunger rod, syringe barrel, label, syringe tip cap, and Luer lock collar. The diagram highlights which parts should not be removed, aiding in proper identification and handling of the syringe components.*

FDA Label Image

Dilau-label-01.jpg (Dilau Label 01)

Label for Dilaudid HydroMorphone HCl Injection, USP 0.5 mg/0.5 mL single-dose injection for subcutaneous, intramuscular, or slow intravenous use. The label shows the brand name, strength, volume, and the labeler Fresenius Kabi USA, LLC.*

FDA Label Image

Dilau-label-02.jpg (Dilau Label 02)

Dilaudid 0.5 mg per 0.5 mL prefilled syringe label for Hydromorphone HCl Injection, USP, by Fresenius Kabi USA, LLC. The label indicates a 0.5 mL single-dose syringe with storage instructions, warnings about dilution and syringe handling, and usage routes including subcutaneous, intramuscular, or slow intravenous use.*

FDA Label Image

Dilau-label-03.jpg (Dilau Label 03)

Dilaudid 0.5 mg per 0.5 mL Injection, USP, hydromorphone hydrochloride injection label for 10 single-dose prefilled syringes. The label includes usage directions for subcutaneous, intramuscular, or slow intravenous use, storage instructions, and cautions such as 'Do NOT dilute for IV push' and 'Do NOT place syringe on a sterile field.' Labeler is Fresenius Kabi USA, LLC.*

FDA Label Image

Dilau-label-04.jpg (Dilau Label 04)

Label for Dilaudid Hydromorphone HCl Injection, USP, 0.2 mg/mL strength. The label specifies that it is for SC, IM, or slow IV use in a 1 mL single-dose format. The labeler is Fresenius Kabi USA, LLC. The label includes a volume scale up to 1 mL and a barcode at the bottom.*

FDA Label Image

Dilau-label-05.jpg (Dilau Label 05)

Dilaudid 0.2 mg/mL injection label shows hydromorphone hydrochloride in a 1 mL single-dose prefilled syringe. Instructions include storage at 20° to 25°C, protection from light, and warnings against dilution for IV push and placing syringe on sterile field. Labeler is Fresenius Kabi USA, LLC.*

FDA Label Image

Dilau-label-06.jpg (Dilau Label 06)

Packaging label for Dilaudid 0.2 mg/mL injection, USP by Fresenius Kabi USA, LLC. Label indicates 10 x 1 mL single-dose prefilled syringes for subcutaneous, intramuscular, or slow intravenous use. The label includes handling instructions, storage conditions, and a barcode.*

FDA Label Image

Dilau-label-07.jpg (Dilau Label 07)

Label for Dilaudid Hydromorphone HCl Injection, USP, 1 mg/mL strength. It is a 1 mL single-dose vial intended for subcutaneous, intramuscular, or slow intravenous use. The label includes measurement marks from 0.5 mL to 1 mL, branding for Fresenius Kabi, and a barcode with a numeric code.*

FDA Label Image

Dilau-label-08.jpg (Dilau Label 08)

Label for Dilaudid Hydromorphone HCl Injection USP, 1 mg/mL concentration. It is a 1 mL single-dose prefilled syringe intended for subcutaneous, intramuscular, or slow intravenous use. Storage instructions, usage warnings, and the labeler Fresenius Kabi USA, LLC are noted. The label also includes a twist cap to open indication.*

FDA Label Image

Dilau-label-09.jpg (Dilau Label 09)

Packaging label for Dilaudid 1 mg/mL Injection, USP with active ingredient hydromorphone HCl. The carton indicates a package of 10 single-dose prefilled 1 mL syringes. Labeler is Fresenius Kabi USA, LLC. Directions include use for subcutaneous, intramuscular, or slow intravenous injection, with warnings not to dilute for IV push or place syringe on a sterile field. Package storage and handling instructions are also included.*

FDA Label Image

Dilau-label-10.jpg (Dilau Label 10)

Dilaudid 2 mg/mL Injection label showing hydromorphone hydrochloride as the active ingredient. The label includes dosage volume markings for 0.5 mL and 1 mL, indicates single-dose 1 mL vial usage for SC, IM, or slow IV administration, and displays the labeler name Fresenius Kabi USA, LLC.*

FDA Label Image

Dilau-label-11.jpg (Dilau Label 11)

Label for Dilaudid hydromorphone hydrochloride injection, USP, 2 mg/mL strength, in a 1 mL single-dose prefilled syringe. Instructions and storage conditions are noted, including use for subcutaneous, intramuscular, or slow intravenous injection. Labeler is Fresenius Kabi USA, LLC with NDC 76045-010-01.*

FDA Label Image

Dilau-label-12.jpg (Dilau Label 12)

Packaging label for Dilaudid 2 mg/mL Injection, USP by Fresenius Kabi USA, LLC. The label states the product is for subcutaneous, intramuscular, or slow intravenous use and includes dosage instructions, storage conditions, and warnings against dilution for IV push. The package contains 10 single-dose 1 mL prefilled syringes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.